[R01] Sustained Release of Potent Antiviral Prodrugs for HIV Prevention

Ente: National Institute of Allergy and Infectious Diseases

Scadenza: 2027-05-31

Importo max: $808,442

Paese: US

Descrizione

Important progress in curbing the progression of the HIV epidemic has been achieved, but new HIV infection rates are outpacing the targets set by global health organizations: in 2019, an estimated 1.7 million people became newly HIV infected worldwide. New HIV pre-exposure prophylaxis (PrEP) strateg

Settori: National Institute of Allergy and Infectious Diseases

Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.